Association between Circulating Thrombopoietin Levels and Cardiovascular Risk Prediction Scores in Renal Transplant Recipients
Conclusion: TPO levels are increased in RTR with high CRCRTR-MACE, particularly in smokers with diminished eGFR. Circulating TPO may serve as a biomarker and treatment target for CVD in RTR.Am J Nephrol 2015;41:147-155
Source: American Journal of Nephrology - Category: Neurology Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Neurology | Smokers | Study | Transplants | Urology & Nephrology